Gossamer Bio’s $212 Million Private Placement Financing

Latham & Watkins represented Gossamer Bio in the transaction.Gossamer Bio, Inc. (Nasdaq: GOSS) announced that it has entered into a securities purchase agreement with institutional and…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

This content is for Standard 1 Year members only.
Login Join Now